The German group has come late to antibody testing, but has punchy accuracy data and a possible means of neutralising some of the competition.
Medtronic has had a poor quarter owing to the pandemic – but Zimmer’s has been even worse.
Abbott’s coronavirus RNA test can ID NOW – but maybe not definitively.
Robust specificity data mark Roche’s serological test out as a major competitor.
Covid-19 could mean Medtronic loses out to Abbott, its rival in the mitral valve space.
With the prevalence of coronavirus infection running at about 5%, test manufacturers and regulators alike will have to guard against false positives.
Diagnostics prove defensive for Abbott, as the company jumps the FDA’s gun with its third coronavirus test.
The FDA is loosening its rules on the authorisation of diagnostic tests for the new coronavirus, but it is still some way behind Europe.
For diabetes devices interoperability is key, and partnerships between Insulet, Dexcom and Abbott show that rival groups see the benefits of working together.